Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Alderley Park Ventures Ltd investment portfolio

Alderley Park Ventures Ltd has made numerous investments in companies such as Nanosyrinx, Kinomica, and Metalinear within the Biotech sector.

vc
Portfolio
7
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (7)

CompanySectorCitySourceLast confirmed on
Bivictrix Therapeutics Limited
BiVictriX Therapeutics develops next‑generation multispecific antibody‑drug conjugates (ADCs) using its proprietary Bi‑Cygni® platform to create highly cancer‑selective therapies for solid tumours and haematological malignancies.
Healthcare & Life SciencesMacclesfieldConfirmed2025-06-21
Kinomica Limited
Kinomica develops and provides the KScan® phosphoproteomic diagnostic platform, which uses LC‑MS/MS and proprietary bioinformatics to profile cell‑signalling pathways for precision oncology and drug‑selection decisions. Its services target clinicians and pharmaceutical researchers who need to match cancer patients with the most appropriate therapies.
Healthcare & Life SciencesMacclesfieldConfirmed2025-12-22

Sign up to see the full portfolio

+5 more companies

Sign up

Shareholding changes (4)

Alderley Park Ventures Ltd's positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+2 more changes

Sign up

Articles (2)